Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
6.88
-0.27 (-3.78%)
At close: Apr 21, 2026
Market Cap4.34B +23.0%
Revenue (ttm)267.70M +7.9%
Net Income-235.06M
EPS-0.37
Shares Out630.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,634,890
Average Volume11,282,922
Open7.12
Previous Close7.15
Day's Range6.81 - 7.18
52-Week Range5.34 - 9.20
Beta0.61
RSI44.72
Earnings DateApr 21, 2026

About SHA:688238

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2025, SHA:688238's revenue was 267.70 million, an increase of 7.88% compared to the previous year's 248.15 million. Losses were -235.06 million, -26.96% less than in 2024.

Financial Statements